Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Description

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Conditions

Corona Virus Infection, Flu Vaccine, Immunity

Study Overview

Study Details

Study overview

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Condition
Corona Virus Infection
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 13 through 64 years
  • * Diagnosed with COVID-19 at least 2 months prior enrollment
  • * Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
  • * Patients without COVID-19 diagnosis for controls
  • * Received the influenza vaccine less than 4 months ago
  • * Pregnant or lactating
  • * Patients with special risks attendant to venipuncture
  • * Use of immunomodulatory medications
  • * Immunodeficiency or autoimmune disease

Ages Eligible for Study

13 Years to 64 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Stanford University,

Sayantani Sindher, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2026-03